BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Cernea S, Onișor D, Roiban AL, Benedek T, Rat N. Metabolic dysfunction-associated steatotic liver disease-associated fibrosis and cardiac dysfunction in patients with type 2 diabetes. World J Cardiol 2024; 16(10): 580-594 [PMID: 39492975 DOI: 10.4330/wjc.v16.i10.580]
URL: https://www.wjgnet.com/1948-5182/full/v16/i10/580.htm
Number Citing Articles
1
Wei Wang, Charlie Cooper. Metabolic dysfunction-associated steatotic liver disease and type 2 diabetes: A dual threat to cardiac dysfunction progressionWorld Journal of Cardiology 2025; 17(1): 102467 doi: 10.4330/wjc.v17.i1.102467
2
Danusia Onișor, Andrada Larisa Roiban, Simona Cernea. Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Patients—The Relationship with Platelets IndicatorsMedicina 2024; 60(12): 2091 doi: 10.3390/medicina60122091